ELV Elevance Health, Inc.

NYSE elevancehealth.com


$ 344.00 $ 0.00 (0 %)    

Friday, 17-Oct-2025 04:09:18 EDT
QQQ $ 590.94 $ 0.00 (0 %)
DIA $ 454.51 $ 0.00 (0 %)
SPY $ 651.88 $ 0.00 (0 %)
TLT $ 91.52 $ 0.00 (0 %)
GLD $ 398.94 $ 0.00 (0 %)
$ 348.18
$ 347.73
$ 342.00 x 4
$ 346.23 x 1
-- - --
$ 272.22 - $ 454.26
1,162,452
na
78.4B
$ 0.56
$ 14.63
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-17-2025 06-30-2025 10-Q
2 04-22-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 10-17-2024 09-30-2024 10-Q
5 07-17-2024 06-30-2024 10-Q
6 04-18-2024 03-31-2024 10-Q
7 02-21-2024 12-31-2023 10-K
8 10-18-2023 09-30-2023 10-Q
9 07-19-2023 06-30-2023 10-Q
10 04-19-2023 03-31-2023 10-Q
11 02-15-2023 12-31-2022 10-K
12 10-19-2022 09-30-2022 10-Q
13 07-20-2022 06-30-2022 10-Q
14 04-20-2022 03-31-2022 10-Q
15 02-16-2022 12-31-2021 10-K
16 10-20-2021 09-30-2021 10-Q
17 07-21-2021 06-30-2021 10-Q
18 04-21-2021 03-31-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 10-28-2020 09-30-2020 10-Q
21 07-29-2020 06-30-2020 10-Q
22 04-29-2020 03-31-2020 10-Q
23 02-19-2020 12-31-2019 10-K
24 10-23-2019 09-30-2019 10-Q
25 07-24-2019 06-30-2019 10-Q
26 04-24-2019 03-31-2019 10-Q
27 02-20-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 07-25-2018 06-30-2018 10-Q
30 04-25-2018 03-31-2018 10-Q
31 02-21-2018 12-31-2017 10-K
32 10-25-2017 09-30-2017 10-Q
33 07-26-2017 06-30-2017 10-Q
34 04-26-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-02-2016 09-30-2016 10-Q
37 07-27-2016 06-30-2016 10-Q
38 04-27-2016 03-31-2016 10-Q
39 02-19-2016 12-31-2015 10-K
40 10-28-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 humana-loses-court-battle-over-medicare-advantage-ratings-billions-in-payments-at-risk

Texas court rules against Humana, upholding Medicare Advantage bonus cuts and risking billions in insurer revenue tied to star ...

 morgan-stanley-maintains-equal-weight-on-elevance-health-raises-price-target-to-359

Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from...

 goldman-sachs-initiates-coverage-on-elevance-health-with-neutral-rating-announces-price-target-of-343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health (NYSE:ELV) with a Neutral rating and announces Pric...

 b-of-a-securities-maintains-neutral-on-elevance-health-raises-price-target-to-370

B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target fr...

 mizuho-maintains-outperform-on-elevance-health-raises-price-target-to-420

Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $342 to $420.

 barclays-maintains-overweight-on-elevance-health-raises-price-target-to-395

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $373 to ...

 guggenheim-maintains-buy-on-elevance-health-raises-price-target-to-398

Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $360 to $...

 wells-fargo-maintains-overweight-on-elevance-health-raises-price-target-to-412

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $...

 sp-500-nasdaq-100-dow-russell-2000-all-soar-to-record-highs-whats-moving-markets-friday

Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday...

 ubs-maintains-buy-on-elevance-health-lowers-price-target-to-425

UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $435 to $425.

 barclays-maintains-overweight-on-elevance-health-raises-price-target-to-373

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $327 to ...

 elevance-health-reaffirms-2025-earnings-per-share-of-approximately-2410-vs-consensus-of-2525-and-adjusted-eps-of-approximately-30-vs-2989-8k-filing

Officers of Elevance Health, Inc. (the "Company") expect to speak with investors over the next several weeks. During th...

 elevance-loses-lawsuit-over-medicare-advantage-quality-ratings--stat-news

https://www.statnews.com/2025/08/19/elevance-loses-medicare-advantage-star-ratings-lawsuit/

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION